Market revenue in 2023 | USD 195.0 million |
Market revenue in 2030 | USD 369.3 million |
Growth rate | 9.5% (CAGR from 2023 to 2030) |
Largest segment | Diagnostics |
Fastest growing segment | Therapeutics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Diagnostics, Therapeutics |
Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Jubilant Pharmova, Nordion, Bracco, Iren SpA, Abliva AB, Lantheus Holdings Inc, Eckert & Ziegler Bebig SA, Mallinckrodt PLC Ordinary Shares - New, Cardinal Health Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nuclear medicine market will help companies and investors design strategic landscapes.
Diagnostics was the largest segment with a revenue share of 78.36% in 2023. Horizon Databook has segmented the Brazil nuclear medicine market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2018 to 2030.
Development of new nuclear reactors for the production of Mo-99 is expected to boost market growth in Brazil. The Brazilian Multipurpose Research Reactor (RMB) is expected to start its operation by 2023 and is likely to produce 1,000 six-day Ci/week of Mo-99. Increasing number of government initiatives, such as funding and awareness programs, is expected to drive the market in Brazil.
For instance, in July 2018, Brazil-based Sociedade Brasileira de Medicina Nuclear (SBMN) signed an agreement with IAEA to provide training to radiopharmaceuticals specialists in Latin America and the Caribbean (LAC) region. Presence of research centers developing radiopharmaceuticals using nuclear reactor is expected to boost market growth.
IPEN (The Nuclear and Energy Research Institute) is a government agency—associated with the Ministry of Economic Development, Science, Technology and Innovation as well as managed technically & administratively by the CNEN (National Nuclear Energy Commission), which is an agency of MCTI (the Ministry of science, technology and innovation of Brazil)—that helps extend the benefits of nuclear energy to larger segments of population.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil nuclear medicine market , including forecasts for subscribers. This country databook contains high-level insights into Brazil nuclear medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account